Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita
Author:
Affiliation:
1. Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany
2. Institute of Cutaneous Cell Biology, Kurume University, Kurume, Japan
Funder
Universität zu Lübeck
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1517/14728222.2016.1148686
Reference166 articles.
1. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review
2. Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions
3. Epidermolysis Bullosa Acquisita
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita;Journal of Investigative Dermatology;2020-12
2. Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin;Frontiers in Immunology;2019-05-14
3. Epidermolysis Bullosa Acquisita: The 2019 Update;Frontiers in Medicine;2019-01-10
4. Role of immune cells in the ocular manifestations of pemphigoid diseases;Therapeutic Advances in Ophthalmology;2019-01
5. Diagnosis of Autoimmune Blistering Diseases;Frontiers in Medicine;2018-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3